Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT03979534
Recruiting Not applicable

Protecting Kidneys Through a Low Protein Diet: A Stepwise Multiple-Choice System Approach

NCT03979534 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier le Mans
Phase
Not applicable
Started
2019-04-01
Last updated
2026-07-01

Condition(s) studied

Chronic Kidney Diseases

Investigational drug(s) / intervention(s)

low protein diet

low protein diet: Patients will be managed with a restricted protein intake (controlled protein diets with a mean target at 0.6 g / kg / day of protein, according to a choice of dietary approaches, adapted to the situation of each patient).

Study summary

Nephrology care continues to progress and recommendations are now focused on delaying as much as possible the need for renal replacement therapy ("intent-to-defer"strategy). Protein restriction is a valuable tool for stabilizing chronic kidney disease (CKD) and retarding the need for renal replacement therapy, but the best diet to be prescribed is still matter of discussion. This study is aimed at identifying implementation strategies for nutritional management of advanced CKD.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All adult patients followed on the unit for advanced CKD, with Kidney disease stage 4-5 or stage 3 with fast progression and without contraindications. Exclusion Criteria: * Malnutrition or short life-expectancy * Patients aged less than 18 years old * Pregnant women, * Incapacity to complete the free-consent form, * Pateints refusing participation in the study, * Patients without healthcare coverage.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Pôle Santé Sarthe et Loir La Flèche France Recruiting
Centre Hospitalier Le Mans Le Mans France Recruiting

More Centre Hospitalier le Mans trials in France

Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment Starting soon
The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil Recruiting
Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease Recruiting
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures Starting soon
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care Recruiting

Other trials for the same condition

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases Recruiting
Pyrophosphate and Arterial Calcification in Chronic Kidney Disease Active, not recruiting
Kynurenine Concentrations During Pregnancy in Women With or Without Chronic Kidney Disease - A Prospective Multicenter Study Starting soon
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients. Recruiting
Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03979534 on ClinicalTrials.gov ↗ ← All trials in France